Transplant Diagnostics Market By Technology-
Transplant Diagnostics Market By Product & Service-
Transplant Diagnostics Market By Application-
Transplant Diagnostics Market By Transplant Type-
Transplant Diagnostics Market By End-User-
Transplant Diagnostics Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Transplant Diagnostics Market Snapshot
Chapter 4. Global Transplant Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis
5.1. by Technology & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
5.2.1. Molecular assay technologies
5.2.1.1. PCR-based molecular assays
5.2.1.2. Real-time PCR
5.2.1.3. Sequence-specific primer-PCR
5.2.1.4. Sequence-specific Oligonucleotide-PCR
5.2.1.5. Other PCR-based molecular assays
5.2.2. Sequencing based molecular assays
5.2.2.1. Sanger sequencing
5.2.2.2. Next generation sequencing
5.2.2.3. Other sequencing based molecular assays
5.2.3. Non molecular assays technologies
Chapter 6. Market Segmentation 2: by Product & Service Estimates & Trend Analysis
6.1. by Product & Service & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product & Service:
6.2.1. Reagents & Consumables
6.2.2. Instruments
6.2.3. Software & Services
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Diagnostic Application
7.2.1.1. Pre-Transplantation Diagnostics
7.2.1.1.1. Infectious Disease Testing
7.2.1.1.2. Histocompatibility Testing
7.2.1.1.3. Blood Profiling
7.2.1.2. Post -Transplantation Diagnostics
7.2.2. Research Applications
Chapter 8. Market Segmentation 4: by Transplant Type Estimates & Trend Analysis
8.1. by Transplant Type & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Transplant Type:
8.2.1. Solid Organ Transplantation
8.2.1.1. Kidney Transplantation
8.2.1.2. Liver Transplantation
8.2.1.3. Heart Transplantation
8.2.1.4. Lung Transplantation
8.2.1.5. Pancreases Transplantation
8.2.1.6. Other Organs Transplantation
8.2.2. Stem Cell Transplantation
8.2.3. Soft Tissue Transplantation
8.2.4. Bone Marrow Transplantation
Chapter 9. Market Segmentation 5: by End-user Estimates & Trend Analysis
9.1. by End-user & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
9.2.1. Hospitals and Transplant centers
9.2.2. Research &Academic Institutes
9.2.3. Independent reference laboratories
Chapter 10. Transplant Diagnostics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.1.2. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
10.1.3. North America Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.1.4. North America Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.1.5. North America Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.1.6. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.2.2. Europe Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.2.3. Europe Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.2.4. Europe Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.2.5. Europe Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.2.6. Europe Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.3.2. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.3.3. Asia-Pacific Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.3.4. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.3.5. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.3.6. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.4.2. Latin America Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.4.3. Latin America Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.4.4. Latin America Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.4.5. Latin America Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.4.6. Latin America Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.5.2. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.5.3. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.5.4. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.5.5. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.5.6. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abbott Laboratories, Inc.
11.2.2. Adaptive Biotechnologies
11.2.3. Affymetrix, Inc.
11.2.4. altona Diagnostics GmbH
11.2.5. Arquer Diagnostics Ltd
11.2.6. BAG Diagnostics GmbH
11.2.7. Becton, Dickinson and Company,
11.2.8. Biofortuna Limited
11.2.9. BioMerieux SA,
11.2.10. Bio-rad Laboratories, Inc.
11.2.11. Biotype GmbH
11.2.12. Bruker,
11.2.13. CareDx Inc.
11.2.14. CLONIT srl
11.2.15. Diagnóstica Longwood SL
11.2.16. DiaSorin S.p.A.
11.2.17. ELITechGroup
11.2.18. EUROFINS VIRACOR
11.2.19. F. Hoffmann La-Roche AG.
11.2.20. Hologic, Inc.
11.2.21. Horiba Ltd
11.2.22. Illumina, Inc.
11.2.23. Immucor Transplant Diagnostics, Inc.
11.2.24. Laboratory Corporation of America Holdings.
11.2.25. Linkage Biosciences
11.2.26. Luminex Corporation
11.2.27. Merck KGaA
11.2.28. NanoString
11.2.29. Olerup SSP AB
11.2.30. Omixon Ltd.
11.2.31. PathoNostics
11.2.32. Preservation Solutions, Inc.
11.2.33. Qiagen N.V.
11.2.34. Randox Laboratories Ltd.
11.2.35. Stryker
11.2.36. Takara Bio Inc.
11.2.37. Thermo Fisher Scientific,
11.2.38. TransMedics
11.2.39. Transonic
11.2.40. Zimmer Biomet
11.2.41. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.